Abstract
Diarylsulfonylureas represent a class of antitumor agent with significant therapeutic efficacy against rodent and human models of cancer. Despite the exciting preclinical activity of sulofenur, the prototypic agent, clinical activity was poor. Here we review the activity of sulofenur and a second generation diarylsulfonylurea, LY295501 N-[5-(2, 3-dihydrobenzofuryl) sulfonyl]-N'-(3,4-dichlorophenyl)urea, against colon tumor xenografts, and some of the cellular pharmacology of this class of antitumor agents.
References
Mar 15, 1978·Experimental Cell Research·W E Wright
Dec 15, 1992·Biochemical Pharmacology·G F RushG D Ponsler
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·M E O'BrienE Wiltshaw
Apr 1, 1990·Biochemical Pharmacology·P J HoughtonJ A Houghton
Sep 1, 1990·Journal of Medicinal Chemistry·J J HowbertS M Rinzel
Jan 1, 1989·Cancer Chemotherapy and Pharmacology·P J HoughtonG B Grindey
Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C W TaylorM Hamilton
Apr 1, 1995·Anti-cancer Drugs·P J HoughtonJ A Houghton
Jan 6, 1995·Cancer Letters·P C PhelpsB F Trump
Mar 1, 1995·Biochemical Pharmacology·P J HoughtonG B Grindey
Apr 1, 1994·Anti-cancer Drugs·T D BrownW G Satterlee
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·E FreiB A Teicher
May 25, 1993·Biochemical Pharmacology·J SosinskiP J Houghton
Jan 1, 1991·Cancer Communications·J SosinskiP J Houghton
Citations
Jan 13, 2001·Archives of Pharmacal Research·H S LeeS H Jung
Jan 1, 2000·Archives of Pharmacal Research·E Y MoonS J Yoon
Mar 23, 2000·Archives of Pharmacal Research·S H JungC O Lee
Aug 5, 2010·Apoptosis : an International Journal on Programmed Cell Death·Dong-Myung KimShinWu Jeong
Dec 1, 2001·Biochemical Pharmacology·W PiaoJ H Kim
Jul 14, 1999·Cancer Letters·E Y MoonS J Yoon
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A MastrolorenzoC T Supuran
Sep 7, 1999·Bioorganic & Medicinal Chemistry Letters·M J GilV Martínez-Merino
Jan 5, 2001·Journal of Enzyme Inhibition·C T Supuran, A Scozzafava
Sep 17, 1999·Journal of Enzyme Inhibition·A Scozzafava, C T Supuran
Mar 24, 2010·The Mount Sinai Journal of Medicine, New York·Dara CannataDerek LeRoith
Nov 18, 2004·Bioorganic & Medicinal Chemistry Letters·Semi KimSang-Hun Jung
Jul 31, 2002·Biochemical Pharmacology·Chang Woo LeeHwan Mook Kim
Nov 27, 2009·European Journal of Medicinal Chemistry·Magda A El-SherbenyMusa A Ahmed
May 1, 2017·Chemical Biology & Drug Design·Vahid Shafiei-IrannejadNosratollah Zarghami
Nov 27, 2001·British Journal of Cancer·M M AlonsoM Migliaccio
May 16, 2012·Journal of Animal Science·K E HalesJ C MacDonald
Jul 23, 2014·Asian-Australasian Journal of Animal Sciences·Amlan Kumar Patra
Dec 1, 2012·Asian-Australasian Journal of Animal Sciences·Eun Sook Ji, Kyu-Hyun Park
Sep 18, 2013·The Oncologist·Giulia PaselloAdolfo Favaretto
Feb 21, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xiangming GuanJill Pellegrini
Feb 6, 2018·Journal of Medicinal Chemistry·Nicholas A Meanwell